Clinical Trials Browser

Phase 2 × Gliosarcoma × poly ICLC × Clear all

NCT00262730 2019-06-12

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Phase 2 Completed

97 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT00052715 2018-07-18

Poly-ICLC

Phase 2 Terminated

31 enrolled 8 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma